文献速递胃肠外科

胃癌手术中荧光成像与吲哚菁绿用于前哨淋巴结示踪:洲际德尔菲调查结果

Use of fluorescence imaging and indocyanine green for sentinel node mapping during gastric cancer surgery: Results of an intercontinental Delphi survey.
PubMed 文献 · Surgery · 2022-01-01

该两轮在线德尔菲调查邀请27名国际专家对79条关于胃癌手术中荧光成像与吲哚菁绿(ICG)用于前哨淋巴结示踪的陈述进行投票,最终61条达成共识。共识包括每象限单次注射ICG、手术当日给药、注射1-5 mL的5 mg/mL ICG、内镜下黏膜下注射及显像不足时重复注射等;前哨淋巴结清扫应限于T1且肿瘤≤4 cm的胃癌,但常规应用前仍需进一步研究。

要点

  • ICG荧光成像可作为前哨淋巴结识别的单一模式,推荐前哨淋巴结 Basin 法。
  • 推荐每瘤周4象限单次注射ICG,手术当日给药,总量1-5 mL的5 mg/mL。
  • 前哨淋巴结清扫应限于T1期且肿瘤直径≤4 cm的胃癌。

核心结论

  • 尽管达成较多共识,该技术常规临床应用前仍需进一步研究。

研究设计与样本

  • 两轮在线德尔菲调查,27名国际专家对79条陈述投票,采用方法学步骤减少偏倚。

主要发现

  • 79条陈述中61条达成共识。
  • 共识包括每瘤周4象限单次注射ICG、手术当日给药、注射1-5 mL的5 mg/mL ICG、内镜下黏膜下注射、显像不足时重复注射。
  • 共识认为ICG荧光成像是可接受的前哨淋巴结识别单一模式,前哨淋巴结 Basin 法更受青睐。
  • 前哨淋巴结清扫应限于T1期且肿瘤直径≤4 cm的胃癌,需进一步研究优化技术。

关键数值与推荐

  • 每瘤周4象限单次注射ICG。
  • 手术当日给予ICG。
  • 注射总量1-5 mL的5 mg/mL ICG。
  • 内镜下注射至黏膜下层。
  • 前哨淋巴结显像不足时可重复注射ICG。

临床怎么用

  • 胃癌手术中可考虑按共识方法使用ICG荧光成像进行前哨淋巴结示踪。
  • 前哨淋巴结清扫应严格限于T1期且肿瘤≤4 cm的胃癌患者。
  • 因证据尚不充分,该技术不宜作为常规临床实践广泛开展。

局限性

  • 德尔菲调查为专家共识,非临床研究证据。
  • 原文未报告共识阈值、投票一致性比例等具体方法学细节。
  • 需进一步研究优化技术以使荧光引导前哨淋巴结清扫适用于常规临床。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Understanding the extent of tumor spread to local lymph nodes is critical to managing early-stage gastric cancer. Recently, fluorescence imaging with indocyanine green has been used to identify and characterize sentinel lymph nodes during gastric cancer surgery, but no published guidelines exist. We sought to identify areas of consensus among international experts in the use of fluorescence imaging with indocyanine green for mapping sentinel lymph nodes during gastric-cancer surgery. METHODS: In this 2-round, online Delphi survey, 27 international experts voted on 79 statements pertaining to patient preparation and contraindications to fluorescence imaging with indocyanine green during gastric cancer surgery; indications; technical aspects; advantages/disadvantages and limitations; and training and research. Methodological steps were adopted during survey design to minimize bias. RESULTS: Consensus was reached on 61 of 79 statements, including giving single injections of indocyanine green into each of the 4 quadrants peritumorally, administering indocyanine green on the same day as surgery, injecting a total of 1 to 5 mL of 5 mg/mL indocyanine green, injecting endoscopically into submucosa, and repeating indocyanine green injections a second time if sentinel lymph node visualization remains inadequate. Consensus also was reached that fluorescence imaging with indocyanine green is an acceptable single-agent modality for sentinel lymph node identification and that the sentinel lymph node basin method is preferred. However, sentinel lymph node dissection should be limited to T1 gastric cancer and tumors ≤4 cm in diameter, and further research is necessary to optimize the technique and render fluorescence-guided sentinel lymph nodes dissection acceptable for routine clinical use. CONCLUSION: Although considerable consensus was achieved, further research is necessary before this technology should be used in routine practice.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Sherwinter DA, Boni L, Bouvet M, et al. Use of fluorescence imaging and indocyanine green for sentinel node mapping during gastric cancer surgery: Results of an intercontinental Delphi survey. Surgery. 2022. PMID: 36427927. doi:10.1016/j.surg.2022.06.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。